 |
 |
|
|
|
Willkommen auf der Seite für die häufig gestellten Fragen (FAQ). Unten finden Sie Antworten auf die häufigsten Fragen von Besuchern dieser Website. Falls Sie zu Ihrer Fragen keine Antwort auf dieser Seite finden, senden Sie uns eine E-Mail unter Mail@attophotonics.com oder rufen Sie uns an. FAQs:Frequently asked questions Who is Attophotonics Biosciences GmbH and in what industry is the company engaged? Attophotonics Biosciences GmbH is a partner within an innovative nanotechnology company network and used to have two strategic business units: nanotechnological products and analytical biotechnology. The first business was established in 1998 (Germany) - a pharmaceutical company was added in 1999 (Austria). In 2004 the Attophotonics Biosciences GmbH was founded in Vienna/Austria partnering with the Schalkhammer KG and adding a focus in POC and diagnostic research as well as smart sensor materials. Growing in size Attophotonics moved 2005 to the TFZ-Center Wiener Neustadt with 4-times more lab and office space. Which companies belong to the company network?Headquartered in Alland (Austria), the group consists of Attophotonics Biosciences GmbH (Wiener Neustadt), Schalkhammer KG (Alland, Lower Austria)and Buchenapotheke Alland (Lower Austria). Who manages Attophotonics Biosciences GmbH? The Chief Executive Officer of Attophotonics Biosciences GmbH is Univ. Prof. Dr. Thomas Schalkhammer the founder of the company. Who manages the Schalkhammer KG? The pharmaceutical branch is headed by Mag. pharm Michaela Schalkhammer. What strategy is Attophotonics Biosciences following?Our aim is to continue to build on our technological lead in specific areas of nanotechnology and in the long term to become market leader in research and development within the areas of our core competencies. With competent partners and strategic alliances, we will occupy market niches and develop new markets. The services are sold world wide. Founder of Attophotonics Biosciences?The Chief Executive Officer of Attophotonics Bioscience Univ. Prof. Dr. Thomas Schalkhammer founded the company as a University Professor of the TUDELFT (The Netherlands) and the Vienna Biocenter (Austria). History of Attophotonics Biosciences GmbH?The know-how and technology is based on know-how of collaborating research groups at the Universities of Vienna and Graz as well as a new link to the FH Wiener Neustadt. The research team was established in 1986 and thus has 20 years of experience in bio- and nanotechnology. Where are Attophotonics Biosciences shares traded? Attophotonics Bioscience is a GmbH and no shares are sold. Who are the majority holders?Currently, Univ. Prof. Dr. Thomas Schalkhammer and Mag. pharm Michaela Schalkhammer KG. Can you send me further information material on Attophotonics Biosciences GmbH? Please send us a mail to: mail@attophotonics.com or fax a request form.
|